Life
Pfizer's Chief Strategy Officer Andrew Baum Resigns Amid Strategic Overhaul
Andrew Baum, who previously served as Pfizer's executive vice president and chief strategy and innovation officer, has stepped down from his position.
Editorial Staff
1 min read
Updated 4 days ago
Summary
Andrew Baum has departed from his role at Pfizer, where he held the title of executive vice president and chief strategy and innovation officer.
Baum, who was formerly an analyst at Citi, was brought in to help revitalize Pfizer's strategic direction.
His resignation raises questions about the future of Pfizer's strategy as the company navigates ongoing challenges in the health sector.
Key Facts
| Fact | Value |
|---|---|
| Former Position | Executive Vice President and Chief Strategy and Innovation Officer at Pfizer |
| Previous Experience | Former Citi analyst |
Updates
- No subsequent updates recorded.